Hypertension and vascular calcification: A vicious cycle?

Journal of Hypertension

Volumn 30, Issue 10, 2012, Pages 1885-1893

  Rattazzi, Marcello ^a   Bertacco, Elisa ^a   Puato, Massimo ^a   Faggin, Elisabetta ^a   Pauletto, Paolo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b OSPEDALE CA FONCELLO   (Italy)

Author keywords

Arterial remodeling; extracellular matrix; hypertension; vascular calcification; vascular stiffness

Indexed keywords

COLLAGEN TYPE 1; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA;

ARTERIAL STIFFNESS; ARTERY CALCIFICATION; BLOOD VESSEL CALCIFICATION; CELL DEATH; CELL DIFFERENTIATION; DIASTOLIC BLOOD PRESSURE; GENE MUTATION; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PULSE WAVE; REVIEW; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; VASCULAR SMOOTH MUSCLE;

EID: 84866541916     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328356c257     Document Type: Review

References (96)

1. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 2010; 7:528-536.
2. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
3. McEniery CM, McDonnell BJ, So A, Aitken S, Bolton CE, Munnery M, et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension 2009; 53:524-531.
4. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007; 50:1-13.
5. Shao JS, Cheng SL, Sadhu J, Towler DA. Inflammation and the osteo-genic regulation of vascular calcification: a review and perspective. Hypertension 2010; 55:579-592.
6. Speer MY, Yang HY, Brabb T, Leaf E, Look A, Lin WL, et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondro-cytes in calcifying arteries. Circ Res 2009; 104:733-741.
7. Rattazzi M, Iop L, Faggin E, Bertacco E, Zoppellaro G, Baesso I, et al. Clones of interstitial cells from bovine aortic valve exhibit different calcifying potential when exposed to endotoxin and phosphate. Arte-rioscler Thromb Vasc Biol 2008; 28:2165-2172.
8. Fadini GP, Albiero M, Menegazzo L, Boscaro E, Vigili de Kreutzenberg S, Agostini C, et al. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res 2011; 108:1112-1121.
9. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K, et al. Multilineage potential of cells from the artery wall. Circulation 2003; 108:2505-2510.
10. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001; 21:1998-2003.
11. Rattazzi M, Bennett BJ, Bea F, Kirk EA, Ricks JL, Speer M, et al. Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells. Arterioscler Thromb Vasc Biol 2005; 25:1420-1425.
12. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004; 110:2226-2232.
13. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel DA, Riggs BL, Khosla S. Circulating osteoblast-lineage cells in humans. N Engl J Med 2005; 352:1959-1966.
14. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386:78-81.
15. Yao Y, Bennett BJ, Wang X, Rosenfeld ME, Giachelli C, Lusis AJ, et al. Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ Res 2010; 107:485-494.
16. Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Hohne W, et al. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 2003; 34:379-381.
17. Johnson K, Polewski M, van Etten D, Terkeltaub R. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1S/S mice. Arterioscler Thromb Vasc Biol 2005; 25:686-691.
18. Anderson HC, Mulhall D, Garimella R. Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab Invest 2010; 90:1549-1557.
19. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87:1055-1062.
20. Drueke TB. Arterial intima and media calcification: distinct entities with different pathogenesis or all the same? Clin J Am Soc Nephrol 2008; 3:1583-1584.
21. Naik V, Leaf EM, Hu JH, Yang HY, Nguyen NB, Giachelli CM, et al. Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res 2012; 94:545-554.
22. Schiffrin EL. Vascular remodeling in hypertension: mechanisms and treatment. Hypertension 2012; 59:367-374.
23. Lemarie CA, Tharaux PL, Lehoux S. Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol 2010; 48:433-439.
24. Puato M, Faggin E, Favaretto E, Bertipaglia B, Rattazzi M, Rizzoni D, et al. Prevalence of fetal-type smooth muscle cells in the media of microvessels from hypertensive patients. Hypertension 2004; 44:191-194.
25. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci 2002; 115 (Pt 14):2817-2828.
26. Arribas SM, Hinek A, Gonzalez MC. Elastic fibres and vascular structure in hypertension. Pharmacol Ther 2006; 111:771-791.
27. Davis EC. Elastic lamina growth in the developing mouse aorta. J Histochem Cytochem 1995; 43:1115-1123.
28. Martyn CN, Greenwald SE. Impaired synthesis of elastin in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension. Lancet 1997; 350:953-955.
29. Wolinsky H. Response of the rat aortic media to hypertension. Morphological and chemical studies. Circ Res 1970; 26:507-522.
30. Mochizuki S, Brassart B, Hinek A. Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem 2002; 277:44854-44863.
31. Kieffer P, Robert A, Capdeville-Atkinson C, Atkinson J, Lartaud-Idjoua-diene I. Age-related arterial calcification in rats. Life Sci 2000; 66:2371-2381.
32. Adijiang A, Higuchi Y, Nishijima F, Shimizu H, Niwa T. Indoxyl sulfate, a uremic toxin, promotes cell senescence in aorta of hypertensive rats. Biochem Biophys Res Commun 2010; 399:637-641.
33. Kanemaru K, Seya K, Miki I, Motomura S, Furukawa K. Calcification of aortic smooth muscle cells isolated from spontaneously hypertensive rats. J Pharmacol Sci 2008; 106:280-286.
34. Rucker RB. Calcium binding to elastin. Adv Exp Med Biol 1974; 48:185-209.
35. Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 2005; 334:524-532.
36. Simionescu A, Simionescu DT, Vyavahare NR. Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. Am J Pathol 2007; 171:116-123.
37. Hosaka N, Mizobuchi M, Ogata H, Kumata C, Kondo F, Koiwa F, et al. Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells. Calcif Tissue Int 2009; 85:523-529.
38. Yasmin, McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja K, et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:372-378.
39. Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, et al. Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension 2007; 50:212-218.
40. Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 2004; 110:3480-3487.
41. Qin X, Corriere MA, Matrisian LM, Guzman RJ. Matrix metalloprotei-nase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol 2006; 26:1510-1516.
42. Bouvet C, Moreau S, Blanchette J, de Blois D, Moreau P. Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol 2008; 28:856-862.
43. Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, Iwamoto Y, et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 2009; 119:1785-1794.
44. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116 (Pt 2):217-224.
45. Ghosh J, Murphy MO, Turner N, Khwaja N, Halka A, Kielty CM, et al. The role of transforming growth factor beta1 in the vascular system. Cardiovasc Pathol 2005; 14:28-36.
46. Yan J, Stringer SE, Hamilton A, Charlton-Menys V, Gotting C, Muller B, et al. Decorin GAG synthesis and TGF-beta signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells. Arte-rioscler Thromb Vasc Biol 2011; 31:608-615.
47. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4:140-156.
48. Santhanam L, Tuday EC, Webb AK, Dowzicky P, Kim JH, Oh YJ, et al. Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res 2010; 107:117-125.
49. Sane DC, Kontos JL, Greenberg CS. Roles of transglutaminases in cardiac and vascular diseases. Front Biosci 2007; 12:2530-2545.
50. Telci D, Collighan RJ, Basaga H, Griffin M. Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide. J Biol Chem 2009; 284:29547-29558.
51. Johnson KA, Polewski M, Terkeltaub RA. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res 2008; 102:529-537.
52. Faverman L, Mikhaylova L, Malmquist J, Nurminskaya M. Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett 2008; 582:1552-1557.
53. Watson KE, Parhami F, Shin V, Demer LL. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol 1998; 18:1964-1971.
54. Nakano-KurimotoR, Ikeda K, UraokaM, NakagawaY, YutakaK, Koide M, et al. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am J Physiol Heart Circ Physiol 2009; 297:H1673-H1684.
55. Chen NX, O'Neill KD, Chen X, Moe SM. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 2008; 23:1798-1805.
56. Ahmad PJ, Trcka D, Xue S, Franco C, Speer MY, Giachelli CM, et al. Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization. Am J Pathol 2009; 175:2686-2696.
57. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38 (Pt 2):581-587.
58. Ding HT, Wang CG, Zhang TL, Wang K. Fibronectin enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells via ERK pathway. J Cell Biochem 2006; 99:1343-1352.
59. Walker-Caprioglio HM, Koob TJ, McGuffee LJ. Proteoglycan synthesis in normotensive and spontaneously hypertensive rat arteries in vitro. Matrix 1992; 12:308-320.
60. Reynertson RH, Roden L. Proteoglycans and hypertension. II. [35S]Sulfate incorporation into aorta proteoglycans of spontaneously hypertensive rats. Coll Relat Res 1986; 6:103-120.
61. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S, Wight TN. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 1994; 144:962-974.
62. Fischer JW, Steitz SA, Johnson PY, Burke A, Kolodgie F, Virmani R, et al. Decorin promotes aortic smooth muscle cell calcification and coloc-alizes to calcified regions in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004; 24:2391-2396.
63. Stephens EH, Saltarrelli JG, Baggett LS, Nandi I, Kuo JJ, Davis AR, et al. Differential proteoglycan and hyaluronan distribution in calcified aortic valves. Cardiovasc Pathol 2011; 20:334-342.
64. Dao HH, Essalihi R, Bouvet C, Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 2005; 66:307-317.
65. Dao HH, Essalihi R, Graillon JF, Lariviere R, De Champlain J, Moreau P. Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension. J Hypertens 2002; 20:1597-1606.
66. Essalihi R, Dao HH, Yamaguchi N, Moreau P. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens 2003; 16:103-110.
67. Niederhoffer N, Bobryshev YV, Lartaud-Idjouadiene I, Giummelly P, Atkinson J. Aortic calcification produced by vitamin D3 plus nicotine. J Vasc Res 1997; 34:386-398.
68. Essalihi R, Zandvliet ML, Moreau S, Gilbert LA, BouvetC, Lenoel C, et al. Distinct effects of amlodipine treatment on vascular elastocalcinosis and stiffness in a rat model of isolated systolic hypertension. J Hyper-tens 2007; 25:1879-1886.
69. Atkinson J. Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences. J Appl Physiol 2008; 105:1643-1651.
70. Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P, Block GA. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 2007; 71:802-807.
71. Temmar M, Liabeuf S, Renard C, Czernichow S, Esper NE, Shahapuni I, et al. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 2010; 28:163-169.
72. Verbeke F, Van Biesen W, Honkanen E, Wikstrom B, Jensen PB, Krzesinski JM, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 2011; 6:153-159.
73. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99:2434-2439.
74. Cecelja M, Jiang B, Bevan L, Frost ML, Spector TD, Chowienczyk PJ. Arterial stiffening relates to arterial calcification but not to noncalcified atheroma in women. A twin study. J Am Coll Cardiol 2011; 57:1480-1486.
75. Sekikawa A, Shin C, Curb JD, Barinas-Mitchell E, Masaki K, El-Saed A, et al. Aortic stiffness and calcification in men in a population-based international study. Atherosclerosis 2012; 222:473-477.
76. Allison MA, Criqui MH, Wright CM. Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24:331-336.
77. Jayalath RW, Mangan SH, Golledge J. Aortic calcification. Eur J Vasc Endovasc Surg 2005; 30:476-488.
78. Jensky NE, Criqui MH, Wright MC, Wassel CL, Brody SA, Allison MA. Blood pressure and vascular calcification. Hypertension 2010; 55:990-997.
79. Bergen AA, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H, et al. Mutations in ABCC6 cause Pseudoxanthoma elasticum. Nat Genet 2000; 25:228-231.
80. St Hilaire C, Ziegler SG, Markello TC, Brusco A, Groden C, Gill F, et al. NT5E mutations and arterial calcifications. N Engl J Med 2011; 364:432-442.
81. Nitschke Y, Baujat G, Botschen U, Wittkampf T, du Moulin M, Stella J, et al. Generalized arterial calcification of infancy and Pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 2012; 90:25-39.
82. Rutsch F, Nitschke Y, Terkeltaub R. Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ Res 2011; 109:578-592.
83. Blumenthal HT, Lansing AI, Wheeler PA. Calcification of the media of the human aorta and its relation to intimal arteriosclerosis, ageing and disease. Am J Pathol 1944; 20:665-687.
84. Eisen A, Tenenbaum A, Koren-Morag N, Tanne D, Shemesh J, Imazio M, et al. Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation 2008; 118:1328-1334.
85. Allison MA, Hsi S, Wassel CL, Morgan C, Ix JH, Wright CM, et al. Calcified atherosclerosis in different vascular beds and the risk of mortality. Arterioscler Thromb Vasc Biol 2012; 32:140-146.
86. Santos RD, Rumberger JA, Budoff MJ, Shaw LJ, Orakzai SH, Berman D, et al. Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortality. Atherosclerosis 2010; 209:131-135.
87. Franklin SS, Gustin WT, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96:308-315.
88. Jaffe IZ, Tintut Y, Newfell BG, Demer LL, Mendelsohn ME. Mineralo-corticoid receptor activation promotes vascular cell calcification. Arte-rioscler Thromb Vasc Biol 2007; 27:799-805.
89. Wu SY, Yu YR, Cai Y, Jia LX, Wang X, Xiao CS, et al. Endogenous aldosterone is involved in vascular calcification in rat. Exp Biol Med (Maywood) 2012; 237:31-37.
90. Armstrong ZB, Boughner DR, Drangova M, Rogers KA. Angiotensin II type 1 receptor blocker inhibits arterial calcification in a preclinical model. Cardiovasc Res 2011; 90:165-170.
91. Derwall M, Malhotra R, Lai CS, Beppu Y, Aikawa E, Seehra JS, et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32:613-622.
92. Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001; 21:817-824.
93. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62:245-252.
94. Monckeberg JG. Calcification confined to the media of the arteries of the extremities and its relation to arteriosclerosis. Virchows Arch 1903; 171:141-167.
95. Murphy WA Jr, Nedden Dz D, Gostner P, Knapp R, Recheis W, Seidler H. The iceman: discovery and imaging. Radiology 2003; 226:614-629.
96. Allam AH, Thompson RC, Wann LS, Miyamoto MI, Nur El-Din AelH, El-Maksoud GA, et al. Atherosclerosis in ancient Egyptian mummies: the Horus study. JACC Cardiovasc Imaging 2011; 4:315-327.